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Potassium channelsSeven day exposure to a low concentration of lead acetate increases nitric oxide bioavailability suggesting a
putative role of K+ channels affecting vascular reactivity. This could be an adaptive mechanism at the initial
stages of toxicity from lead exposure due to oxidative stress. We evaluated whether lead alters the participation
of K+ channels and Na+/K+-ATPase (NKA) on vascular function. Wistar rats were treated with lead (1st dose
4 μg/100 g, subsequent doses 0.05 μg/100 g, im, 7 days) or vehicle. Lead treatment reduced the contractile re-
sponse of aortic rings to phenylephrine (PHE) without changing the vasodilator response to acetylcholine
(ACh) or sodium nitroprusside (SNP). Furthermore, this treatment increased basal O2− production, and apocynin
(0.3 μM), superoxide dismutase (150 U/mL) and catalase (1000 U/mL) reduced the response to PHE only in the
treated group. Lead also increased aortic functional NKA activity evaluated by K+-induced relaxation curves.
Ouabain (100 μM) plus L-NAME (100 μM), aminoguanidine (50 μM) or tetraethylammonium (TEA, 2 mM) re-
duced the K+-induced relaxation only in lead-treated rats. When aortic rings were precontracted with KCl
(60 mM/L) or preincubated with TEA (2 mM), 4-aminopyridine (4-AP, 5 mM), iberiotoxin (IbTX, 30 nM),
apamin (0.5 μM) or charybdotoxin (0.1 μM), the ACh-induced relaxation was more reduced in the lead-
treated rats. Additionally, 4-AP and IbTX reduced the relaxation elicited by SNPmore in the lead-treated rats. Re-
sults suggest that lead treatment promoted NKA and K+ channels activation and these effects might contribute
to the preservation of aortic endothelial function against oxidative stress.
© 2012 Elsevier Inc. Open access under the Elsevier OA license.Introduction
Lead has historically been used in awide variety of human activities,
which has signiﬁcantly increased its emission into the atmosphere
(Patrick, 2006). Therefore, all humans have an associated lead burden
due to exposure to exogenous sources (Levin and Goldberg, 2000).
The adverse effects of lead on the heart and vessels have been previous-
ly demonstrated (Fiorim et al., 2011; Silveira et al., 2010; Vassallo et al.,
2008). Numerous studies have revealed that chronic or acute lead expo-
sure increases oxidative stress (Silveira et al., 2010; Vaziri et al., 1999a),ação em Ciências Fisiológicas,
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sevier OA license.lipid peroxidation (Ding et al., 1998; Vaziri et al., 1999b), and affects an-
tioxidant reserves (Farmand et al., 2005; Vaziri et al., 2003).
Vascular endothelium is highly sensitive to oxidative stress, and
this stress is the main cause of the endothelial dysfunction observed
in cardiovascular diseases such as atherosclerosis, hypertension and
stroke (Chatterje and Catravas, 2008; Forstermann and Munzel, 2006).
It is well established that lead exposure induces endothelial dysfunc-
tion, and therefore, it could be considered an important cardiovascular
risk factor and a serious problem for public health (Patrick, 2006;
Poreba et al., 2011; Silveira et al., 2010; Vaziri et al., 1999a).
Recently, we demonstrated that a 7-day treatment with a low con-
centration of lead acetate increases NO bioavailability and Na+/K+-
ATPase activity in the rat aorta (Fiorim et al., 2011). NO, a short lived
gas, is an important protective molecule in the vasculature, especially
in conductance arteries. NO is synthesized in the endothelium and dif-
fuses from it to the vascular lumen being a potent inhibitor of platelet
aggregation, adhesion and proliferation of vascular smooth muscle
cells, and it prevents the development of atherosclerosis (Chatterje
and Catravas, 2008; Forstermann and Munzel, 2006; Poreba et al.,
2011; Triggle et al., 2003). Thus, in response to various neurohumoral
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vascular smoothmuscle cells. In addition, NO could also stimulate Na+/
K+-ATPase activity (Gupta et al., 1994) and open K+ channels (Bolotina
et al., 1994; Félétou and Vanhoutte, 2006), which contribute to main-
tain adequate vascular function.
The Na+/K+-ATPase is responsible for maintaining the cellular
membrane potential and contributes to the regulation of vascular tone
and blood pressure. Thus, alterations in the Na+/K+-ATPase could be
related to cardiovascular disease (Marín and Redondo, 1999). In a pre-
vious report, it has been shown that chronic lead exposure causes car-
diovascular disease by inhibiting Na+/K+-ATPase (Weiler et al.,
1990). However, our recent studies have shown that acute (Simões et
al., 2011) or 7-day lead exposure increases Na+/K+-ATPase activity
and the expression of the alpha-1 subunits of Na+/K+-ATPase (Fiorim
et al., 2011).
K+ channel activation has been identiﬁed as an important compo-
nent in vascular tone regulation (Ko et al., 2008; Nelson and Quayle,
1995). Activation of K+ channels in vascular smoothmuscle leads to hy-
perpolarization, decreases the activity of voltage-gated L-type Ca2+
channels, reduces [Ca2+]i and induces vasodilation (Ledoux et al.,
2006). Many subtypes of K+ channels have been identiﬁed in endothe-
lial and smooth muscle cells (Félétou, 2009; Félétou and Vanhoutte,
2009; Standen and Quayle, 1998). In vascular smooth muscle cells, Kv
channels are activated bymembrane depolarization in the physiological
range (Nelson and Quayle, 1995), while the large conductance KCa
channels (BKCa) are activated mainly by increases in [Ca2+]i (Eichhorn
andDobrev, 2007; Ledoux et al., 2006). The involvement of K+ channels
in cardiovascular disorders depends on the vascular tissue or species
studied (Ko et al., 2008). Thus, BKCa channels play a key role in regulating
vascular tone in resistance arteries (Briones et al., 2009; Eichhorn and
Dobrev, 2007), while aortic tone is strongly dependent on the activity
of Kv channels (Tammaro et al., 2004).
The regulatory function of the endothelium is altered by cardio-
vascular risk factors or disorders, such as heavy metal exposure
(Silveira et al., 2010; Triggle et al., 2003; Wiggers et al., 2008). We
aimed to evaluate whether K+ channels and Na+/K+-ATPase activa-
tion promoted by 7-day treatment with lead could be a compensatory
mechanism against increased free radical production in the initial
stages of lead exposure. Thus, we analyzed the effects of this treat-
ment on the following: 1) reactive oxygen species (ROS) production
and its participation in vascular responses to vasoconstrictors; 2) in-
volvement of the NO pathway in Na+/K+-ATPase functional activity;
and 3) participation of K+ channels in the relaxation induced by ace-
tylcholine and sodium nitroprusside. Our ﬁndings provide evidence
that the activation of K+ channels and Na+/K+-ATPase prevents the
aortic endothelial dysfunction induced by increased free radicals in
lead-treated rats.
Materials and methods
Animals and treatment. Male Wistar rats (250–300 g) were used
for these studies. The care and use of laboratory animals were in ac-
cordance with the NIH guidelines, and all experiments were con-
ducted in compliance with the guidelines for biomedical research as
stated by the Brazilian Societies of Experimental Biology and were ap-
proved by the Institutional Ethics Committee of the Federal University
of Espirito Santo (CEUA-UFES 052/2011). All rats had free access to
water and were fed with rat chow ad libitum. The rats were divided
into two groups: control (vehicle-saline, intramuscular) or treated
with lead acetate for 7 days (1st dose: 4 μg/100 g, subsequent doses:
0.05 μg/100 g, intramuscular, to cover daily loss). No differences in
bodyweight between the two groupswere observed before (untreated:
260±0.89 g, n=38; lead-treated: 258±0.99 g, n=40; P>0.05) or
after treatment (untreated: 308±2.45 g, n=38; lead-treated: 312±
2.63 g, n=40; P>0.05). At the endof the treatment, the ratswere anes-
thetized with pentobarbital (35 mg/kg, intraperitoneal) and killed byexsanguination. The thoracic aortas were carefully dissected out, and
the fat and connective tissue were removed. For the vascular reactivity
experiments, the aortas were divided into cylindrical segments 4 mm in
length.
Vascular reactivity measurements. The aortic segments were
mounted between two parallel wires in organ baths containing
Krebs–Henseleit solution (KHS, in mM: 124 NaCl, 4.6 KCl, 2.5 CaCl2,
1.2 MgSO4, 1.2 KH2PO4, 0.01 EDTA, 23 NaHCO3) at 37 °C and gassed
with 95% O2–5% CO2 (pH 7.4). The arterial segments were stretched
to an optimal resting tension of 1 g. Isometric tension was recorded
using a force transducer (TSD125C, CA, USA) connected to an acquisi-
tion system (MP100A, BIOPAC System, Inc., Santa Barbara, USA). After
a 45 min equilibration period, all aortic rings were initially exposed
twice to 75 mM KCl. The ﬁrst exposure checks their functional integ-
rity, and the second exposure assesses the maximal tension. Next, en-
dothelial integrity was tested with acetylcholine (ACh, 10 μM) in
segments previously contracted with phenylephrine (1 μM). A relaxa-
tion equal to or greater than 90% was considered demonstrative of the
functional integrity of the endothelium. After a 45-minwashout period,
concentration–response curves to phenylephrine were determined.
Single curves were performed in each segment. The effects of apocynin
(0.3 μM, an inhibitor of NADPH oxidase), superoxide dismutase (SOD)
(150 U/mL) and catalase (1000 U/mL) were investigated by adding
them to the bath 30 min before performing the phenylephrine
concentration–response curves.
In another set of experiments, after the 45-min equilibration period,
aortic rings from untreated and lead-treated rats were pre-contracted
with phenylephrine (1 μM) or 60 mmol/L KCl, and the concentration–
response curves to ACh (0.1 nM–300 μM) were determined. The role
of NO in the relaxation induced by ACh was analyzed by incubating
the vessels with NG-nitro-L-arginine methyl ester (L-NAME, 100 μM,
nonspeciﬁc NOS inhibitor) for 30 min before phenylephrine or KCl ad-
ministration. The contribution of K+ channels to ACh-induced relaxa-
tion was assessed in aortas previously incubated for 30 min with the
K+ channel blockers tetraethylammonium (TEA, 2 mM, nonselective
blocker of K+ channels), 4-aminopyridine (4-AP, 5 mM, Kv blocker),
iberiotoxin (IbTX, 30 nM, selective BKCa blocker), apamin (0.5 μM, se-
lective blocker of small-conductance Ca2+-activated K+ channels —
SKCa) and charybdotoxin (ChTX, 0.1 μM, blocker of KCa and Kv).
In some experiments, the concentration–response curves to sodium
nitroprusside (SNP, 0.01 nM–0.3 μM)were performed in segments con-
tractedwith phenylephrine (1 μM). The role of the Kv and BKCa channels
in the SNP-induced relaxation was analyzed by incubating the vessels
with 4-AP and IbTX, respectively, for 30 min before phenylephrine ad-
ministration. The inﬂuence of the endothelium on the response to SNP
in untreated and lead-treated rats was investigated after its mechanical
removal, which was performed by rubbing the lumen with a needle.
The absence of endothelium was conﬁrmed by the inability of 10 μM
acetylcholine (ACh) to produce relaxation.
The functional activity of the Na±/K+-ATPase was measured in
segments from untreated and lead-treated rats using K+-induced re-
laxation, as described by Weeb and Bohr (1978) and modiﬁed by
Rossoni et al. (2002). After a 30-min equilibration period in normal
Krebs, the preparations were incubated for 30 min in K+-free Krebs.
The vessels were subsequently pre-contracted with phenylephrine,
and once a plateau was attained, the KCl concentration was increased
stepwise (1, 2, 5 and 10 mM) with each step lasting for 2.5 min. After
a washout period, the preparations were incubated with 100 μM oua-
bain (OUA) for 30 min to inhibit sodium pump activity, and the K+-
induced relaxation curve was repeated. To study the involvement of
NO, inducible NO synthase (iNOS) and K+ channels in OUA-
sensitive Na+K+-ATPase functional activity, the rings were incubated
with L-NAME (100 μM), aminoguanidine (50 μM) and TEA (2 mM),
respectively. Moreover, the inﬂuence of the endothelium was investi-
gated, repeating the same protocols after its mechanical removal.
Table 1
Effects of apocynin, SOD and catalase on the vascular response to phenylephrine (Rmax
and pD2) in aortas from untreated and lead-treated rats.
Untreated Lead treated
Rmax pD2 Rmax pD2
Control 81.80±4.74 6.55±0.10 66.22±4.66# 6.29±0.06
Apocynin 82.15±9.69 6.25±0.15 47.23±5.22* 6.15±0.10
SOD 79.70±3.71 6.32±0.08 51.19±5.32* 6.07±0.06*
Control 94.12±4.07 6.11±0.10 78.18±0.71& 5.99±0.12
Catalase 92.39±3.73 5.93±0.15 66.61±1.53+ 5.86±0.10
The results are expressed as mean±SEM of the number of animals shown in Fig. 1.
Rmax, maximal effect (expressed as a percentage of the maximal response induced by
75 mM KCl); pD2, − log one-half Rmax. Pb0.05 vs. untreated control rats (#&) and
lead-treated control rats (*+). Note that apocynin and SOD incubation have one control
and catalase has another one.
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− production. The oxidative ﬂuorescent
dye dihydroethidium (DHE) was used to evaluate O2− production in
situ, as previously described by Wiggers et al. (2008). Hydroethidine
freely permeates cells and is oxidized in the presence of O2− to
ethidium bromide, which is trapped by intercalation with DNA.
Ethidium bromide is excited at 546 nm and has an emission spectrum
of 610 nm. Frozen tissue segments were cut into 10-μm-thick sections
and placed on a glass slide. Serial sections were equilibrated under
identical conditions for 30 min at 37 °C in Krebs–HEPES buffer (in
mM: 130 NaCl, 5.6 KCl, 2 CaCl2, 0.24 MgCl2, 8.3 HEPES, and 11 glucose,
pH=7.4). Fresh buffer containing DHE (2 μM) was applied topically to
each tissue section, covered with a cover slip, incubated for 30 min in a
light-protected humidiﬁed chamber at 37 °C, and then viewed with a
inverted ﬂuorescence microscope (NIKON Eclipse Ti-S, x40 objective)
using the same imaging settings in the untreated and lead-treated
rats. Fluorescence was detected with a 568-nm long-pass ﬁlter. For
quantiﬁcation, eight frozen tissue segments per animal were sampled
for each experimental condition and averaged. The mean ﬂuorescence
densities in the target region were calculated.Statistical analyses. All values are expressed as the mean±standard
error of the mean (SEM). Contractile responses to phenylephrine
were expressed as a percentage of the maximal response induced by
75 mM KCl. Vasodilator responses to ACh or SNP were expressed as
the percentage of relaxation of the previous contraction.
For each concentration–response curve, the maximal effect (Rmax)
and the concentration of agonist that produced 50% of the maximal
response (log EC50) were calculated using non-linear regression analy-
sis (GraphPad Prism, GraphPad Software, Inc., San Diego, CA). The sen-
sitivities of the agonists were expressed as pD2 (− log EC50). To
compare the effects of L-NAME, TEA, 4-AP, IbTX, ChTX and apamin on
the relaxation responses to ACh, some resultswere expressed as the dif-
ferences in the area under the concentration–response curves (dAUC)
for the control and experimental groups. These values indicatewhether
the magnitude of the effect of L-NAME, TEA, 4-AP, IbTX, ChTX and
apamin is different in the untreated or lead-treated rats.
The results were expressed as the mean±SEM of the number of
rats indicated (n). The differences were analyzed using Student's t-test
or two-way ANOVA followed by a Bonferroni test. Pb0.05 was consid-
ered to be signiﬁcant.Drugs and reagents. Lead acetate, l-phenylephrine hydrochloride,
ACh chloride, SNP, sodium pentobarbital, apocynin, SOD, catalase,
OUA, L-NAME, TEA, 4-AP, IbTX, CbTX and apamin were purchased
from Sigma-Aldrich (St. Louis, USA). The salts and reagents used
were of analytical grade from Sigma-Aldrich and Merck (Darmstadt,
Germany).Table 2
Effects of NG-nitro-L-arginine methyl ester (L-NAME), tetraethylammonium (TEA), 4-
aminopyridine (4-AP), iberiotoxin (IbTX), apamin and charybdotoxin (ChTX) on the
vascular responses to acetylcholine (Rmax and pD2) in phenylephrine contracted aortas
from untreated and lead-treated rats.
Untreated Lead treated
Rmax pD2 Rmax pD2
Control 99.91±0.09 7.12±0.13 99.80±0.10 7.11±0.09
L-NAME 6.91±3.51# 7.14±0.58 6.91±2.86* 7.11±0.09
TEA 71.90±2.47# 6.62±0,12# 59.69±3.16* 5.72±0.31*
4-AP 88.84±3.03 6.45±0.22# 54.03±2.46* 6.72±0.52
IbTX 94.14±2.48# 6.40±0.18# 81.43±4.36* 6.44±0.18*
Apamin 91.65±2.22# 6.87±0.09 91.47±2.23* 6.45±0.07*
ChTX 92.01±1.88# 6.93±0.08 90.41±3.19* 6.42±0.13*
The results are expressed as mean±SEM of the number of animals shown in Figs. 2, 3,
4 and 5. Rmax, maximal effect; pD2, − log one-half Rmax. Pb0.05 vs. untreated control
rats (#) and lead-treated control rats (*).Results
Effects of lead treatment on vascular reactivity
Lead exposure did not affect the response to KCl (untreated E+:
3.46±0.04 g, n=38; lead-treated E+: 3.43±0.11 g, n=40; untreated
E−: 3.49±0.03 g, n=20; lead-treated E−: 3.43±0.09 g, n=20;
P>0.05). Pre-contraction to phenylephrine used before performing
ACh and SNP relaxation curves was similar in the groups (untreated
E+: 2.46±0.05 g, n=10; lead-treated E+: 2.63±0.03 g, n=10;
untreated E−: 2.55±0.11 g, n=10; lead-treated E−: 2.57±0.04 g,
n=10 P>0.05). However, this metal reduced vascular reactivity to
phenylephrine in the aortic rings (Table 1). However, lead did not
change the relaxation induced by acetylcholine (Table 2) or the relaxa-
tion produced by SNP (Table 3).Effect of lead treatment on oxidative stress
The basal O2− production in the aortas from the lead-treated rats
was greater than that from the controls (Fig. 1A). To investigatewhether
the vascular oxidative stress induced by lead treatment was involved in
the observed alterations of vascular reactivity to phenylephrine, we
used apocynin (0.3 nM), which is a NADPH oxidase inhibitor; SOD,
(150 U/mL), which is a superoxide anion scavenger; and catalase
(1000 U/mL), which is a hydrogen peroxide scavenger. These drugs re-
duced the vasoconstrictor response induced by phenylephrine in the
aortas from lead-treated rats but did not in the aortas from untreated
rats (Figs. 1B–D and Table 1).
Effects of lead treatment on Na+/K+-ATPase activity
We previously reported that lead treatment for 7 days increased
the activity of the sodium pump and protein expression of the Na+/
K+-ATPase alpha-1 subunit in aortic rings from treated rats (Fiorim
et al., 2011). After endothelium removal, the KCl-induced relaxation
was reduced in the aortic rings from both groups (Fig. 2A), but this re-
duction was greater in the aortas from lead-treated rats. To investi-
gate the involvement of NO in Na+/K+-ATPase activity, we used L-
NAME (100 μM), a nonselective NOS inhibitor, and aminoguanidine
(50 μM), a selective iNOS inhibitor. After incubating the rings with
L-NAME, the KCl-induced relaxation was reduced in the aortic rings
from both groups (Fig. 2B), but this reduction was greater in the aortas
from the treated group compared to the untreated rats. Incubationwith
aminoguanidine did not modify the relaxation induced by potassium in
aortas from untreated rats but reduced the relaxation induced by potas-
sium in lead-treated rats (Fig. 2C). Similarly, after coincubation of the
Table 3
Effects of 4-aminopyridine (4-AP) and iberiotoxin (IbTX) on the vascular response to
sodium nitroprusside (Rmax and pD2) in phenylephrine contracted aortas from
untreated and lead-treated rats.
Untreated Lead treated
Rmax pD2 Rmax pD2
Control 99.90±0.10 7.49±0.07 99.96±0.10 7.37±0.06
IbTX 99.47±0.83 6.35±0.10# 91.50±2.20* 6.57±0.10*
4-AP 93.26±2.04# 6.77±0.17# 89.01±2.39* 6.55±0.16*
The results are expressed as mean±SEM of the number of animals shown in Fig. 6.
Rmax, maximal effect; pD2, − log one-half Rmax. Pb0.05 vs. untreated control rats (#)
and lead-treated control rats (*).
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Fig. 1. Vascular superoxide anion production in segments of aorta from untreated and lead-
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induced relaxation was reduced in aortic rings from treated rats but
not in aortas from untreated rats (Figs. 2B and C). After endothelium re-
moval, incubationwithOUA, further reduced theKCl-induced relaxation
in aortic rings from both groups (Fig. 2A), but this reductionwas greater
in aortas from lead-treated rats. These results reinforce the previous
ﬁndings regarding the increase of NKA activity after lead treatment.
The K+ channel blocker TEA (2 mM) did not modify the relaxation
induced by potassium in aortas from untreated rats but reduced that
relaxation in lead-treated rats. However, after coincubation with OUA
(100 μM), the KCl-induced relaxation was not different compared to
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Fig. 2. The effects of endothelium removal (A), NG-nitro-L-arginine methyl ester (L-NAME, 100 μM) (B), aminoguanidine (AG, 50 μM) (C) and TEA (2 mM) (D) on potassium-
induced relaxation in the aortic rings from untreated and lead-treated rats previously incubated in a K+-free medium and contracted with phenylephrine before and after incuba-
tion with 100 μM ouabain (OUA). The results are expressed as mean±SEM. aPb0.05 (untreated E− or L-NAME vs. untreated E+); *Pb0.05 (treated E− or L-NAME or AG or TEA vs.
treated E+); &Pb0.05 (untreated OUA E− vs. untreated OUA E+) #Pb0.05 (treated OUA E− or L-NAME or AG vs. treated OUA E+), all by two-way ANOVA followed by a Bonferroni
test. The number of animals is indicated in parentheses.
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As mentioned, the endothelium-dependent relaxation induced by
ACh in arteries pre-contracted with phenylephrine was similar in aortic
rings fromuntreated and lead-treated animals (Table 2). In arteries pre-
contracted with 60 mmol/L KCl, the relaxation induced by ACh was re-
duced both in untreated (Rmax for phenylephrine pre-contraction:
99.91±0.09%, n=10; for KCl pre-contraction: 56.14±2.83%, n=10,
Pb0.05) and lead-treated rats (Rmax for PHE pre-contraction: 99.99±
0.01%, n=10; for KCl pre-contraction: 25.97±3.29% n=10, Pb0.05).
However, this reduction was much more marked in arteries obtained
from lead-treated rats (Fig. 3A). The participation of NO in ACh-
induced relaxation was investigated using L-NAME (100 μM), which
was added before phenylephrine or high K+. Under these conditions,
the relaxation induced by ACh was negligible in arteries from both
groups contracted with either phenylephrine (Fig. 3B) or KCl (Fig. 3C),
indicating that NO accounted for most of the endothelium-dependent
relaxation. However, the greater reduction in ACh relaxation observed
in arteries from lead-treated rats pre-contracted with KCl compared to
untreated rats suggests a different contribution of hyperpolarizing
mechanisms in the aortas fromboth groups. Therefore, we tested the ef-
fects of some potassium channel blockers on the basal tone and relaxa-
tion induced by ACh.
TEA (2 mM), a nonselective K+ channel blocker, and 4-AP (5 mM),
a speciﬁc inhibitor of Kv channels, increased the basal tone in aortic
segments from both groups, but these effects were greater in the
lead-treated rats compared to the untreated rats (Fig. 4A), suggesting
a relevant role for Kv channels in controlling arterial tone. In addition,
TEA and 4-AP reduced the relaxation induced by ACh in aortic seg-
ments from both groups (Figs. 4B, D and Table 2), and this effect
was greater in preparations from lead-treated rats compared to
untreated rats as shown by the dAUC values (Figs. 4C and E).To evaluate the role of KCa channels, the aortic rings were incubated
with the selective BKCa blocker (IbTX), the selective SKCa blocker
(apamin) and the KCa and Kv blocker (ChTX). Only iberiotoxin increased
the basal tone in aortic segments from the lead-treated and untreated
rats, but this effect was similar in both groups (Fig. 4A). Moreover, the
three calcium-activated potassium channel inhibitors reduced the re-
laxation induced by ACh in aortic segments from both groups
(Figs. 5A, C, E and Table 2). However, this effect was greater in prepara-
tions from lead-treated than untreated rats as shown by the dAUC
values (Figs. 5B, D and F).
Because lead treatment increases the contribution of Kv and Kca
channels upon ACh-induced relaxation, which is mainly mediated by
NO,we analyzed the participation of these K+ channels in the relaxation
induced by the NO donor, SNP. The endothelium-independent relaxa-
tion induced by SNP in arteries pre-contracted with phenylephrine
was similar in aortic rings from untreated and lead-treated animals
(Table 3). After IbTX and4-AP incubation, therewas a decrease in the re-
laxation induced by SNP in aortic segments from either group (Figs. 6A,
C and Table 3), and this decrease was greater in preparations from lead-
treated than untreated rats, as shown by the dAUC values (Figs. 6B and
D). Endothelium removal did not affect SNP relaxation in any group,
being the relaxation induced by the NO donor similar between groups
(Fig. 6E).
Discussion
The results presented here show that a 7-day treatment with a
low concentration of lead acetate increased free radicals production, de-
spite the reduction in vascular reactivity to phenylephrine, but did not
change the relaxation induced by ACh and SNP. On the other hand,
our ﬁndings also suggest that activation of the K+ channel as well as
the increased Na+/K+ ATPase activity masked a putative endothelial
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stress.
Lead has been identiﬁed as a hazard and risk factor for developing
cardiovascular diseases (Navas-Acien et al., 2007). The Agency for
Toxic Substances and Disease Registry (ATSDR) considers the reference
blood lead concentration level to be 60 μg/dL (ATSDR, 2005; Kosnett et
al., 2007; Patrick, 2006). Several studies have supported the association
between high blood lead levels and hypertension (Glenn et al., 2006;
Harlan, 1988; Navas-Acien et al., 2007). In a recent study, using con-
trolled lead administration, we found a blood lead concentration of
9.98 μg/dL after a 7-day treatment with a low dose of lead acetate
(Fiorim et al., 2011). Although this value was below the blood lead
reference, it was sufﬁcient to increase SBP and to decrease the contrac-
tile responses induced by phenylephrine in the rat aorta. In accordance,
a blood lead concentration of 37 μg/dL (below the blood lead reference)
that was reached after acute administration also induced an increase in
SBP (Simões et al., 2011). Thus, these results provide guidance for revising
the lead concentrations considered to be safe.Several studies have shown that lead exposure in animals or
humans induces the generation of ROS with subsequent oxidative
damage to several organs and systems and also alters antioxidant de-
fense systems (Ding et al., 1998; Farmand et al., 2005; Ni et al., 2004;
Vaziri et al., 1999b). Similarly, we observed increased superoxide
anion production in the aorta from lead-treated rats. In addition, the
inhibition of NADPH oxidase as well as SOD and catalase reduced
the vasoconstrictor response induced by phenylephrine only in the
aortas from lead-treated rats, suggesting that both superoxide anion
production and hydrogen peroxide are involved in the vascular alter-
ations promoted by lead. In agreement, Silveira et al. (2010) demon-
strated the involvement of free radicals after acute administration of
lead acetate in the tail vascular bed reactivity. Ni et al. (2004) showed
that lead exposure increased superoxide and hydrogen peroxide pro-
duction in coronary endothelial cells.
Despite the involvement of ROS in this experimental model, which
could increase vasoconstriction, we previously observed a decrease in
vascular reactivity to phenylephrine in the aortas from lead-treated
rats and an increase in the modulator effects by NO (Fiorim et al.,
2011). Other investigators have also demonstrated that incubation
with 1 ppm lead acetate for 24 h increases NOproduction in endothelial
cells from human coronary arteries (Vaziri and Ding, 2001). Further-
more, several reports have suggested that lead exposure increases the
expression of iNOS in aorta (Vaziri et al., 1999a, 1999b, 2001; Fiorim
et al., 2011), heart (Vaziri et al., 2001) and kidney (Gonick et al., 1997;
Vaziri et al., 2001). NO produces vasodilation of the vascular smooth
muscle cells in all types of blood vessels, especially in conductance ar-
teries. Moreover, NO could also stimulate Na+/K+-ATPase activity
(Gupta et al., 1994) and open K+ channels (Bolotina et al., 1994;
Félétou and Vanhoutte, 2006, 2009), which contribute to reduced vas-
cular tone.
The activation of Na+/K+-ATPase activity is an important mecha-
nism contributing to the maintenance of vascular tone and mem-
brane potential in vascular smooth muscle cells (Blaustein, 1993;
Marín and Redondo, 1999). We previously reported that a 7-day
treatment with a low concentration of lead acetate increased the pro-
tein expression of the Na+/K+-ATPase alpha-1 subunit and Na+/K+-
ATPase activity in the rat aorta (Fiorim et al., 2011). K+-induced re-
laxation was used as an index of Na+/K+-ATPase functional activity
(Weeb and Bohr, 1978). Endothelium removal and the non speciﬁc
NOS inhibitor L-NAME reduced such relaxation more in aortic rings
from lead-treated compared to the untreated rats, and the iNOS in-
hibitor aminoguanidine only had effect in rings from treated rats.
These ﬁndings suggest that the increased of Na+/K+-ATPase func-
tional activity induced by lead could be mediated by the NO pathway.
In addition to guanylate cyclase activation, NO is also a hyp-
erpolarizing factor that increases K+ channel permeability (Bolotina
et al., 1994; Félétou and Vanhoutte, 2006). Our results showed that
the non speciﬁc K+ channels blocker TEA did not modify K+-induced
relaxation in the aortas from untreated rats but reduced it in treated
rats. After co-incubation of the rings with TEA plus OUA, K+-induced
relaxation was not different between the groups, suggesting a similar
action between K+ channels and Na+/K+ATPase activity in the lead-
treated rats.
Lead treatment did not modify ACh-induced relaxation in phenyl-
ephrine pre-contracted aortas, as previously reported (Fiorim et al.,
2011). The importance of endothelial NO in controlling vascular
tone in conductance arteries is well established (Urakami-Harasawa
et al., 1997; Félétou and Vanhoutte, 2006). In agreement, we found
that ACh-induced relaxation in the aorta was entirely dependent on
NO release because it was abolished by L-NAME. As mentioned, NO
can also hyperpolarize vascular smooth muscle cells by activating dif-
ferent K+ channels, depending on the vascular bed or species studied
(Bolotina et al., 1994; Félétou and Vanhoutte, 2006, 2009; Félétou et
al., 2010). ACh induced-relaxation was partially blocked by high K+
concentration suggesting that it is mediated, in part, by K+ channels
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Fig. 4. The contractile effect induced by TEA (2 mM), 4-aminopyridine (4-AP, 5 mM) and iberiotoxin (IbTX, 30 nM) in aortas from untreated and lead-treated rats (A). The results
are expressed as mean±SEM *Pb0.05 vs. untreated TEA and #Pb0.05 vs. untreated 4-AP, Student's t-test. The effect of TEA (2 mM) (B) and 4-AP, (5 mM) (D) on the concentration–
response curves to acetylcholine (ACh) in endothelium-intact aortic segments from untreated and lead-treated rats. The inset shows differences in dAUC in the absence and presence of
TEA (C) or 4-AP (E). aPb0.05 (untreated TEA or 4-AP vs. untreated); #Pb0.05 (treated TEA or 4-AP vs. treated); *Pb0.05 (untreated vs. treated % dAUC), all by Student's t-test. The number
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obtained from lead-treated rats. The residual relaxation to ACh in high-
KCl precontracted vessels was abolished by L-NAME indicating an addi-
tional effect of NO, independent of K+ channel activation, on ACh-
induced relaxation.
TEA was initially used to evaluate the overall contribution of K+
channels to the basal tone and ACh-induced relaxation. TEA increased
basal tone more in preparations from the lead-treated rats compared
to the untreated rats and reduced the relaxation induced by ACh more
in aortic segments from the lead-treated than untreated group; these
results suggest a greater contribution of K+ channels in both basal
tone and ACh-induced relaxation after lead treatment. Accordingly,
Fiorim et al. (2011) observed that TEA potentiated the phenylephrineresponse more strongly in aortic rings from lead-treated rats compared
to untreated rats. In addition, patch clamp observations of K+ currents
in human erythrocytes showed that lead exposure activates K+ chan-
nels (Kempe et al., 2005).
Different K+ channels are involved in cardiovascular disorders, such
as atherosclerosis, hypertension and stroke (Nelson and Quayle, 1995;
Callera et al., 2004; Ledoux et al., 2006). Lead treatment increased NO
bioavailability in the rat aorta (Fiorim et al., 2011) and as mentioned
NO could open K+ channels. Therefore, we investigated the participa-
tion of diverse K+ channels in regulating basal tone and in NO-
mediated ACh-induced relaxation in lead-treated rats. It has been
shown that aortic tone is strongly dependent on the activity of Kv chan-
nels (Tammaro et al., 2004). In addition, Cheong et al. (2002) also has
CE
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Our results showed that 4-aminopyridine, a selective inhibitor of Kv
channel, induced a greater increase in basal tone in aortic segments
from lead-treated than in untreated rats. Furthermore, this inhibitor re-
duced the relaxation induced by ACh to a greater extent in preparations
from lead-treated compared to untreated rats. These results suggest
that Kv channels contribute to the regulation vascular tone in the rat
aorta and that channels contribute more to the basal tone and ACh-
induced relaxation in the lead-treated rats.
Several studies have shown that BKCa plays a key role in regulating
vascular tone in different beds (Cheong et al., 2002; Eichhorn and
Dobrev, 2007; Briones et al., 2009), and the activation of these channels
is an important component of the EDHF response in several vascular
beds (Ledoux et al., 2006). Our results show that both charybdotoxin
(KCa and Kv blocker) and apamin (selective SKCa blocker) did notmodify
basal tone in aortic segments from both groups. However, iberiotoxin
increased the basal tone in the same way in aortic segments from
untreated and lead-treated rats suggesting that BKCa similarly contributesto the basal tone in the rat aorta. Similar results were reported by
Briones et al. (2009) in coronary arteries from ouabain treated and
untreated rats. Regarding the involvement of calcium-activated K+
channels on ACh-induced relaxation, our results showed that ChTX,
IbTX and apamin reduced the relaxation induced byACh to a greater ex-
tent in the lead-treated than in the untreated group, suggesting that
lead treatment increases the participation of Kv, BKCa and SKCa in the
endothelium-dependent relaxation induced by ACh.
As mentioned before, the L-NAME effect on ACh relaxation indi-
cates that NO is the main factor responsible for such relaxation in
the aorta. Furthermore, it is known that BKCa and Kv channels are pre-
sent in the vascular smooth muscle (Nelson and Quayle, 1995;
Félétou and Vanhoutte, 2009). Similar to the results observed with
ACh, the endothelium-independent relaxation induced by SNP was
not affected by lead treatment. Importantly, after IbTX or 4-AP incu-
bation, there was a greater decrease in the relaxation induced by
SNP in aortic segments from the lead-treated rats compared to the
untreated rats. These results suggest that both BKCa and Kv channels
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ute to a greater extent in lead-treated rats. However, we cannot discard
alterations inNO-derived cGMP-dependentmechanisms after lead treat-
ment and more experiments would be necessary to clarify this issue.
In summary, our results show that a 7-day treatment with a low
concentration of lead acetate increases free radical production, de-
spite the reduction in vascular reactivity to phenylephrine and did
not change the relaxation induced by ACh and SNP. Our results also
suggest that the activation of K+ channels and increased Na+/K+
ATPase activity mask putative endothelial dysfunction in lead-
treated rats. Moreover, activation of Kv and BKCa channels seems to
contribute more to the control of vascular tone in the aorta from
lead-treated rats. Recently, using this experimental model, we
showed that lead exposure increased NO bioavailability and reduced
vascular tone (Fiorim et al., 2011). Our ﬁndings suggest that the acti-
vation of K+ channels and Na+/K+ ATPase could reduce vascular tone
in the initial stages of lead exposure that counteracts the vasocon-
strictor action of free radicals. In fact, lead exposure, at low concentra-
tions, could be considered an important cardiovascular risk factor and
a serious problem for public health.Conﬂict of interest statement
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